Second, staining with the diagnostic B cell marker B220 indicates that the CAG-A3B mice are developing predominantly B cell lymphomas, either de novo or from preceding lymphoid hyperplasias (Figures 4F, S4A, and S4B). Here, PTPRC is linked to B-cell non-Hodgkin lymphoma.